These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16497638)

  • 1. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
    Wasilewska A; Zoch-Zwierz W; Tenderenda E
    Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome.
    Wasilewska A; Zoch-Zwierz W
    Acta Paediatr; 2006 May; 95(5):587-93. PubMed ID: 16825140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF; Brodeh J
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.
    Wasilewska A; Zoch-Zwierz W; Pietruczuk M
    Eur J Pediatr; 2007 May; 166(5):447-52. PubMed ID: 17024347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Wierciński R; Winiecka W; Smółko M; Porowski T; Koput A; Janicka K
    Pol Merkur Lekarski; 2003 Aug; 15(86):172-5. PubMed ID: 14648986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors.
    Wasilewska AM; Zoch-Zwierz WM
    Pediatr Nephrol; 2004 Dec; 19(12):1349-53. PubMed ID: 15490252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
    Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K; Kołodziejczyk Z
    Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia].
    Yang HQ; Zhang RH; Zhang ZH; Wan CC; Xia YJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):526-8. PubMed ID: 18082030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine experience in nephrotic syndrome.
    Phadke K; Ballal S; Maiya V
    Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.
    Wasilewska A; Zoch-Zwierz W; Tobolczyk J; Tenderenda E
    Pediatr Nephrol; 2007 Mar; 22(3):403-8. PubMed ID: 17115196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
    Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
    Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome.
    Cheong HI; Lee JH; Hahn H; Park HW; Ha IS; Choi Y
    J Nephrol; 2001; 14(4):263-9. PubMed ID: 11506248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
    Xia ZK; Liu GL; Gao YF; Fu J; Fu YF; Zhang LF; Fan ZM
    Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
    Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome].
    Tenderenda E; Korzeniecka-Kozerska A; Porowski T; Wasilewska A; Zoch-Zwierz W
    Pol Merkur Lekarski; 2011 Oct; 31(184):204-8. PubMed ID: 22097175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.